The startup operates a clinical research healthcare company that provides approved treatments and disease detection services while conducting clinical trials. By facilitating access to professional medical care, it addresses the need for inclusive healthcare solutions for patients facing harmful diseases.
Funding
$7.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The development of new therapies is often hindered by barriers to clinical research participation, leading to delays in bringing potentially life-saving treatments to market. Many communities lack access to clinical trials, resulting in underrepresentation and limiting the generalizability of research findings.
Solution
Alcanza Clinical Research accelerates the development of new therapies by operating a network of clinical research sites focused on inclusive research practices. The company reduces barriers to clinical trial participation by providing health education and clinical research options to diverse patient populations. Alcanza collaborates with medical providers and community-based organizations to deliver high-quality clinical research opportunities. The company's certified research professionals conduct all research activities with patient safety and data integrity as top priorities.
Target Audience
Alcanza Clinical Research serves pharmaceutical sponsors, clinical research organizations (CROs), healthcare providers, and patients seeking access to cutting-edge treatment options through clinical trial participation.
Features
- Network of dedicated clinical research facilities across multiple states and Puerto Rico
- Multi-phase clinical trial execution (Phase I-IV)
- Expertise in a wide range of therapeutic areas, including oncology
- Centralized patient recruitment strategies to enhance enrollment efficiency
- Diversity, Equity, and Inclusion (DEI) initiatives to engage historically underrepresented patient populations
- Centralized Quality Management Plan (QMP) with proactive monitoring and detection systems
- Medical Advisory Board providing medical oversight and guidance
- Phase 1 capabilities with multiple site locations offering inpatient trial facilities
- Strategic partnerships with sponsors and CROs to streamline communication and study execution